sunitinib, optionally in the form of a pharmaceutically acceptable salt, and the salt l-malate (capsules)

摘要

The present invention relates to pyrrole substituted 2-indolinone compounds and their pharmaceutically acceptable salts which modulate the activity of protein kinases and therefore are expected to be useful in the prevention and treatment of protein kinase related cellular disorders such as cancer.